Back to Awarded Treatment Trials


Awarded Trial: 01T-046

Grant ID

01T-046

Illness

Schizophrenia

Primary Drug/Intervention

Tiagabine

Primary Dosage

16 mg b.i.d.

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Woo

Sample Size

40

Duration of Study Period for Each Subject

12 months

Outcome Measurements

PANSS, working memory, volumetric MRI

Results

Grant terminated due to poor enrollment.

Publication

N/A

Link

N/A

PI Name

Tsung-Ung Woo

Degree

MD

Center

McLean Hospital

Institution

N/A

Address

Laboratory for Structural Neuroscience, 115 Mill Street

City or Town

Belmont

State or Province

MA

Zip or Postal Code

2478

Country

USA

Email Address

wilson_woo@hms.harvard.edu